Valuation
- Market cap
- 419,702,000
- Revenue TTM
- $35,260,000
- Net income TTM
- $-69,110,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -196.00%
- Debt to equity
- 0.62
Trading
- Volume
- 1,119,500
- Avg volume
- 785,846
- Day's range
- $9.69 – $10.61
- Shares out
- 41,803,000
- Stochastic %K
- 45%
- Beta
- 1.04
- Analysts
- Moderate Buy
- Price target
- $14.00
Company profile
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin se...
Show more
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 301 515 7260
- Website
- https://www.senseonics.com
- Address
- 20451 Seneca Meadows Parkway, Germantown, United States
Latest news
No headlines yet.
Stocktwits
jisaac82
Nov 13, 9:13 PM
$SENS this will most likely tick up post ER but generally, bears are starting to understand whats good for them.
0 replies
jisaac82
Nov 13, 4:56 PM
$SENS this guy blocked me cause I asked if hes concerned about his short 😭😭. Turns out he was...
1 replies
PattyPooner
Nov 13, 11:43 AM
$SENS 10 might become the new floor as we have tested below twice since earnings but have closed above all week. Need more time to digest but price action looking good. Luckily there’s no need to worry about Goodnow sleeping around.
0 replies
devilinblue
Nov 13, 3:59 AM
$SENS I asked Chat gbt if Sens could possibly go after the animal market at some point and found this: And there is something worth knowing:
Eversense has already been tested in diabetic dogs.
A 2022 veterinary study evaluated the Eversense XL implantable glucose monitor in three diabetic dogs.
Two dogs used the sensor for its full 180-day lifespan.
Glucose readings correlated well with other monitoring devices.
The dogs generally tolerated the implant.
Sensor movement and calibration requirements were limitations. 
0 replies
HaliburtonResearch
Nov 12, 7:02 PM
$SENS Some warnings to consider -
Negative Cash Flow: Number of Years: 10; Operating Cash Flow: -113; Equity: 78
Negative Earnings: EPS: -
$2.27; Earnings Yield: -21.9%
High Short Percent: Short % of Float: 8.9%
High Stock Based Compensation: Compensation Yield: 2.1%
Earnings Misses: Number of Quarters: 6; EPS Surprise: -2.04%
Price Pullback: Price vs 52-wk High (%): 74.3%; 52-wk High Date: 11/10/26
2 replies
stoley
Nov 12, 1:19 PM
$SENS
I really hope the positive momentum continues—but not too fast, otherwise profit-taking sets in. 3–4 percent a day—steady, just the way I like it.
0 replies
